Dear John,

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will hold its first meeting under new Health and Human Services leadership on June 25, from 8 a.m. to 5 p.m. EDT, June 26, from 8 a.m. to 5 p.m.,EDT, and June 27, 8 a.m. to 3 p.m. EDT.

Among several topics up for discussion and voting is what’s next for COVID-19 shots. The time allotted for public comment provides a great opportunity to tell the new committee members exactly what we think of COVID shots. Let’s give it to them straight: There is no scientific justification for continuing a program for a vaccine that doesn’t prevent transmission or infection – so take it off the market!

As mainstream media continues imploding over news of HHS Secretary Kennedy’s clean sweep of ACIP,  let’s welcome the new members by letting them know we take great interest in every one of these meetings and our voices will not be silenced.

Be sure to take action no later than the June 20 deadline. Comments will not be accepted after 11:59 p.m. ET on Friday.

We need to let ACIP know that, in addition to being ineffective when it comes to preventing transmission or infection, COVID shots:

• Can’t be justified when, prior to the availability of COVID shots, “the median infection fatality rate of COVID-19 was estimated to be 0.034% for people aged 0–59.”
• Have resulted in a 318% higher mortality rate among quadruple-jabbed youth compared to those who skipped the shot.
• Have led to unprecedented accounts of death and injury following vaccination with VAERS reporting 1,664,527 injuries including 38,666 deaths as of May 30, 2025.
• Pose egregious health threats to our nation’s children – including infants as young as six months old.

In addition to COVID shots, the committee will also be discussing vaccines for anthrax, chikungunya, cytomegalovirus (CMV), Human papillomavirus (HPV), influenza, Lyme disease, meningococcal disease, pneumococcus, Respiratory Syncytial Virus (RSV) vaccines for adults, and RSV vaccines for maternal and pediatric populations.

Recommendation vaccine votes are scheduled for HPV, influenza, meningococcal disease, RSV vaccines for adults, and RSV vaccine for maternal and pediatric populations. Vaccines for Children (VFC) votes are scheduled for COVID-19, HPV, influenza, and RSV.

With such a huge number of vaccines on the agenda, now is the perfect time to emphasize the need for double-blind inert placebo studies on all vaccines before they can be brought to the market. This gold standard of scientific investigation has not been applied to vaccines on the routine childhood schedule. The methodology of vaccine study has to change to protect our nation’s children from the risks of poorly-tested products.

The June 25–27 meeting will take place in Atlanta. If you’re going to be in the area and would like to make a comment in person, you need to submit a request at https://www.cdc.gov/acip/meetings/index.html before 11:59 p.m. EDT, June 20, 2025.

Written public comments must also be received by June 20. Just use the button below and you can use the suggested reply as written, or edit it to include your own points.

Join us in telling the new committee members they have an opportunity – and a duty – to end ACIP’s long tradition of prioritizing Pharma profits at the expense of public health.

Thank you for taking action.

The Children’s Health Defense Team